BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23362163)

  • 21. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New and enlarging white matter lesions adjacent to the ventricle system and thalamic atrophy are independently associated with lateral ventricular enlargement in multiple sclerosis.
    Sinnecker T; Ruberte E; Schädelin S; Canova V; Amann M; Naegelin Y; Penner IK; Müller J; Kuhle J; Décard B; Derfuss T; Kappos L; Granziera C; Wuerfel J; Magon S; Yaldizli Ö
    J Neurol; 2020 Jan; 267(1):192-202. PubMed ID: 31612322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment.
    Giesel FL; Hahn HK; Thomann PA; Widjaja E; Wignall E; von Tengg-Kobligk H; Pantel J; Griffiths PD; Peitgen HO; Schroder J; Essig M
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1454-8. PubMed ID: 16908557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S; Pareto D; Tintoré M; Vidal-Jordana A; Alyafeai R; Alberich M; Sastre-Garriga J; Auger C; Montalban X; Rovira À
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset.
    Meijerman A; Amiri H; Steenwijk MD; Jonker MA; van Schijndel RA; Cover KS; Vrenken H;
    AJNR Am J Neuroradiol; 2018 Jan; 39(1):46-53. PubMed ID: 29191870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis.
    Popescu V; Battaglini M; Hoogstrate WS; Verfaillie SC; Sluimer IC; van Schijndel RA; van Dijk BW; Cover KS; Knol DL; Jenkinson M; Barkhof F; de Stefano N; Vrenken H;
    Neuroimage; 2012 Jul; 61(4):1484-94. PubMed ID: 22484407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
    Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
    J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging.
    Wang D; Chalk JB; Rose SE; de Zubicaray G; Cowin G; Galloway GJ; Barnes D; Spooner D; Doddrell DM; Semple J
    Magn Reson Imaging; 2002 Jan; 20(1):41-8. PubMed ID: 11973028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of mean upper cervical cord area (MUCCA) measurement techniques in multiple sclerosis (MS): High reproducibility and robustness to lesions, but large software and scanner effects.
    Weeda MM; Middelkoop SM; Steenwijk MD; Daams M; Amiri H; Brouwer I; Killestein J; Uitdehaag BMJ; Dekker I; Lukas C; Bellenberg B; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2019; 24():101962. PubMed ID: 31416017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis and validation of automated skull stripping tools: a validation study based on 296 MR images from the Honolulu Asia aging study.
    Hartley SW; Scher AI; Korf ES; White LR; Launer LJ
    Neuroimage; 2006 May; 30(4):1179-86. PubMed ID: 16376107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping hippocampal and ventricular change in Alzheimer disease.
    Thompson PM; Hayashi KM; De Zubicaray GI; Janke AL; Rose SE; Semple J; Hong MS; Herman DH; Gravano D; Doddrell DM; Toga AW
    Neuroimage; 2004 Aug; 22(4):1754-66. PubMed ID: 15275931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates.
    Pipitone J; Park MT; Winterburn J; Lett TA; Lerch JP; Pruessner JC; Lepage M; Voineskos AN; Chakravarty MM;
    Neuroimage; 2014 Nov; 101():494-512. PubMed ID: 24784800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects.
    Sánchez-Benavides G; Gómez-Ansón B; Sainz A; Vives Y; Delfino M; Peña-Casanova J
    Psychiatry Res; 2010 Mar; 181(3):219-25. PubMed ID: 20153146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease.
    Kazemifar S; Drozd JJ; Rajakumar N; Borrie MJ; Bartha R;
    J Neurosci Methods; 2014 Apr; 227():35-46. PubMed ID: 24518149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.
    Durand-Dubief F; Belaroussi B; Armspach JP; Dufour M; Roggerone S; Vukusic S; Hannoun S; Sappey-Marinier D; Confavreux C; Cotton F
    AJNR Am J Neuroradiol; 2012 Nov; 33(10):1918-24. PubMed ID: 22790248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MMSE scores correlate with local ventricular enlargement in the spectrum from cognitively normal to Alzheimer disease.
    Ferrarini L; Palm WM; Olofsen H; van der Landen R; Jan Blauw G; Westendorp RG; Bollen EL; Middelkoop HA; Reiber JH; van Buchem MA; Admiraal-Behloul F
    Neuroimage; 2008 Feb; 39(4):1832-8. PubMed ID: 18160312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated atrophy assessment for Alzheimer's disease diagnosis from brain MRI images.
    Shaikh TA; Ali R
    Magn Reson Imaging; 2019 Oct; 62():167-173. PubMed ID: 31279772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis.
    Lukas C; Minneboo A; de Groot V; Moraal B; Knol DL; Polman CH; Barkhof F; Vrenken H
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1351-6. PubMed ID: 20826873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.